(Q68171747)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Single-Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

15 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

15 October 2022

author name string

C. E. Halstenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

J. Triscari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

A. DeVault

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

B. Shapiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

W. Keane

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

H. Pan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1613121

15 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1613121

15 October 2022

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1992.tb03816.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1992.tb03816.x/fullpdf

15 October 2022

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

The Journal of Clinical Pharmacology

15 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

124-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia

22 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia

15 October 2022

2

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects

15 October 2022

4

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing

15 October 2022

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry

15 October 2022

6

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

15 October 2022

9

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin

15 October 2022

10

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia

15 October 2022

11

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1992.TB03816.X

15 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1613121%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference